Ciprofloxacin +/- piroxicam in men with chronic prostatitis: effects on PSA kinetics

Trial Profile

Ciprofloxacin +/- piroxicam in men with chronic prostatitis: effects on PSA kinetics

Completed
Phase of Trial: Phase II

Latest Information Update: 05 Mar 2012

At a glance

  • Drugs Ciprofloxacin (Primary) ; Piroxicam (Primary)
  • Indications Prostatitis
  • Focus Biomarker; Therapeutic Use
  • Most Recent Events

    • 05 Mar 2012 New trial record
    • 28 Feb 2012 Results presented at the 27th Congress of the European Association of Urology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top